Medium- and short-chain dehydrogenase/reductase gene and protein families
- First Online:
- Cite this article as:
- Kavanagh, K.L., Jörnvall, H., Persson, B. et al. Cell. Mol. Life Sci. (2008) 65: 3895. doi:10.1007/s00018-008-8588-y
- 7k Downloads
Short-chain dehydrogenases/reductases (SDRs) constitute a large family of NAD(P)(H)-dependent oxidoreductases, sharing sequence motifs and displaying similar mechanisms. SDR enzymes have critical roles in lipid, amino acid, carbohydrate, cofactor, hormone and xenobiotic metabolism as well as in redox sensor mechanisms. Sequence identities are low, and the most conserved feature is an α/β folding pattern with a central beta sheet flanked by 2–3 α-helices from each side, thus a classical Rossmannfold motif for nucleotide binding. The conservation of this element and an active site, often with an Asn-Ser-Tyr-Lys tetrad, provides a platform for enzymatic activities encompassing several EC classes, including oxidoreductases, epimerases and lyases. The common mechanism is an underlying hydride and proton transfer involving the nicotinamide and typically an active site tyrosine residue, whereas substrate specificity is determined by a variable C-terminal segment. Relationships exist with bacterial haloalcohol dehalogenases, which lack cofactor binding but have the active site architecture, emphasizing the versatility of the basic fold in also generating hydride transfer-independent lyases. The conserved fold and nucleotide binding emphasize the role of SDRs as scaffolds for an NAD(P)(H) redox sensor system, of importance to control metabolic routes, transcription and signalling.
Keywords.Short-chain dehydrogenases/reductasesreaction mechanismprotein familyoxidoreductaseRossmann foldenzyme evolution
Dehydrogenase family relationships: the ADH paradigm
Based on sequence analyses of insect, yeast and mammalian alcohol dehydrogenases (ADHs) distinct families of NAD(P)(H)-dependent dehydrogenases were postulated well over 25 years ago . This and further studies demonstrated multiple evolutionary steps of ‘enzymogenesis’ leading to the current system of distinct oxidoreductase families, classes and isozymes [2, 3]. The initial observations have held true, and through genome sequencing projects it is now clear that distinct families of dehydrogenases/reductases represent a large group of gene products within nearly every genome [3, 4]. This large representation of oxidoreductases highlights their importance and functional diversity in the physiology of organisms reaching from prokaryotes to mammals . The variety of particular biochemical roles is enormous and comprises many intermediary metabolic functions. Examples are utilization and detoxification of ethanol and xenobiotics in general, regulation of hormones and signalling molecules (e.g. by hydroxy-steroid and prostaglandin dehydrogenases in mammals) or sensing of the redox status in metabolism or transcription, thereby regulating vital cellular processes [5–9].
Whereas the Zn-containing yeast and liver alcohol dehydrogenases (ADHs; members of the family of medium-chain dehydrogenases/reductases, MDRs) have been well characterized [10 – 12], insect and bacterial alcohol and polyol dehydrogenases initially received less attention. At first, these enzymes were found to be different [13, 14] and were considered only of prokaryotic and lower eukaryotic origin. However, the discovery of similarities between these enzymes and human or mammalian prostaglandin, hydroxy-steroid and other dehydrogenases changed the view dramatically [15 – 18]. Based on distinct sequence motifs, protein chain length, mechanistic features and structural comparisons, a system of short-, medium- and long-chain dehydrogenases/reductases has now been established [16, 19, 20]. A typical member of the short-chain dehydrogenases/reductases (SDRs) is Drosophila ADH, while prokaryotic polyol dehydrogenases and eukaryotic glucose 6-phosphate dehydrogenases or UDP-glucose dehydrogenases are now classified into the heterogenous group of long-chain dehydrogenases/reductases (LDR) [20, 21].
A large variability is noticed in the mechanistic and structural details within each family. MDR enzymes either have a Zn-dependent or Tyr-based catalytic mechanism, and consist of two distinct domains (the coenzyme-binding and the catalytic domain). LDRs have a similar domain architecture as MDRs with the active site located in the cleft between the two domains, but frequently utilize a Lys-based catalytic center [21, 30]. Conversely, most SDR members display a simple one-domain architecture with the substrate binding site located in the highly variable Cterminal region, although additional small domains are occasionally observed, as in the case of ‘extended’ SDRs (cf. below) [6, 16]. The catalytic base in the majority of SDRs is a highly but not strictly conserved Tyr residue, giving rise to significant mechanistic differences in SDR subclasses. The degree of three-dimensional conservation indicates that ancestral dehydrogenases existed within each MDR, SDR or LDR family. After multiple gene duplicatory events, these ancestral dehydrogenases gave rise to the present system of subfamilies and classes found within each family. Interestingly, the aldo-keto reductases (AKRs), although structurally belonging to the (α/β)8 or TIM barrel protein family, display an example of convergent evolution with an active site conformation nearly superimposible to that of SDRs with conserved Tyr and Lys residues [8, 16, 31].
SDR: a large protein family
Characterized SDR members in different domains of life as of January 2007.
Domain of life
Number of SDR enzymes in human and model organisms.
Number of SDR enzymes
Redundancy-reduced at 90% identity level
Cofactor and active site sequence motifs for the fiveSDR subfamilies.
Structural and mechanistic aspects of SDR enzymes
The majority of SDRs are oligomeric, with either homodimeric or homotetrameric quaternary structures. In most but not all  cases, the main dimerization interfaces are across two perpendicular twofold axes (P and Q), involving a four-helix bundle and a β-sheet that extends across two subunits . Monomeric SDRs such as carbonyl reductase (CBR) have a long segment of 20-odd residues inserted just before the catalytic Tyr that forms an α-helix, which packs against and stabilizes the helical interaction surface .
‘Classical’ and ‘intermediate’ SDRs
Classical and intermediate SDRs are closely related forms, with ‘intermediate’ forms representing mostly Drosophila ADH. These two classes differ mainly within the Gly-rich cofactor binding region (Table 3), but show a highly similar one-domain architecture. The substrate and reaction spectrum includes mostly NAD(P)(H)-dependent oxidoreduction of hydroxy/keto groups within a large array of small molecules such as steroids, alcohols, polyols, growth factors, xenobiotics and secondary metabolites.
A subfamily of ‘complex’ SDRs was identified through sequence pattern searches . Members of this group are part of large multidomain enzymes, such as mammalian fatty acid synthases and bacterial polyketide synthases. This subfamily displays rudimentary sequence pattern similarities (Table 3) versus the ‘classical’ or ‘extended’ SDRs . Structure determination of the ACP-ketoacyl reductase domain of Streptomyces erythromycin synthase  revealed that all necessary parts of the catalytic machinery, i.e. the Asn, Ser, Tyr and Lys residues, are assembled in a catalytically competent fashion, but are contributed from distinct parts of the general scaffold. Importantly, a previously uncharacterized ‘linker’ region of the polyketide synthase provides a structural domain for oligomerization with the catalytic domain. Further sequence motifs were identified, allowing prediction of the ACP-hydroxyacyl product stereospecificities .
Numbers of SDR families and enzymes with assignments of EC classes 1, 4 and 5.
All SDR types
Total EC 1+4+5
Mechanistically, the best-characterized member of the extended SDR family is UDP-galactose epimerase (GALE) [52, 57, 69–72]. It catalyzes the interconversion between UDP-glucose and UDP-galactose and constitutes a central step of the Leloir pathway in the metabolism of galactose. The enzyme contains a tightly bound NAD+ molecule, which stays attached and undergoes different redox state changes during the reaction cycle. In the first step of the reaction, a concerted proton abstraction from the 4′OH of the substrate and hydride transfer from the substrate C4 to the S-face of the nicotinamide cofactor occurs [52, 55, 69, 71, 73–76]. The resulting 4-ketopyranose intermediate rotates within the active site around the phosphate bond by about 180°, thus presenting the opposite side of the sugar to NADH. In the last part of the reaction cycle, the carbonyl substrate is reduced by hydride transfer from NADH in alliance with the initial catalytic base, with the net result being a stereochemical inversion of the substrate hydroxyl group. Variable sizes of the active site pockets between Escherichia coli and human GALE give rise to the observed different substrate specificities and also explain the ability of the human enzyme to catalyze conversion of UDP-N-acetylglucosamine and UDP-N-acetylgalactosamine .
Extensive mutagenetic, kinetic and crystallographic data confirm the roles of Tyr149 (numbering as in the E. coli structure) and Ser124 as central catalysts in the SDR-type of epimerases [52, 55, 69, 71, 73–76]. The presence of a charge transfer band between NAD+ and the epimerase strongly suggests a deprotonated tyrosine residue of importance, and together with the extensive mechanistic investigations on Drosophila ADH enforces the concept of tyrosine as the central acid/base catalyst in SDRs. UDP binding to the nucleotide-diphosphate domain enhances reactivity of NAD+, suggesting cooperative behaviour between the UDP binding domain and the central catalytic domain. Whether this observation holds true for other extended SDR types such as dehydratases or decarboxylases is unknown at present.
Another important category of SDR-type isomerases is the mammalian 3β-hydroxy-5ene-steroid isomerases, involved in the synthesis of all classes of steroid hormones and bile acids [77–79]. No crystal structure of these enzymes has been solved yet. Mechanistically best-studied is the type I 3β-HSD-Δ5 isomerase, which in a sequential reaction first oxidizes the 3β-hydroxyl group in a manner involving the conserved Tyr, Lys and Ser residues. This is followed by NADH-induced activation of an isomerase-competent domain, likely to involve Asp and Tyr residues as catalytic acid/base catalysts  involved in proton transfer at steroid positions C4 and C6, similar to amechanism described for a bacterial steroid isomerase [80, 81].
Several members of the extended SDR family catalyze dehydration of important diphosphonucleotide-activated carbohydrates like GDP-mannose or dTDP-glucose. For example, in humans the essential carbohydrate GDP-fucose is synthesized from GDP-mannose via two distinct SDR enzymes: first, an intermediate GDP-4-keto-6-deoxymannose is produced in the GDP-mannose dehydratase (GMDH) reaction, and this is then further metabolized via GDP-4-keto-6-deoxymannose epimerase/reductase (TSTA 2) to the GDP-fucose product .
The catalytic mechanism of GMDH, based on bacterial and plant orthologs [83, 84], involves an initial NADP+-dependent oxidation of the 4′OH group of the mannose, followed by a proton abstraction from the C5′ carbon, subsequent protonation of the C6′OH, resulting in loss of a water molecule and formation of a 4-keto, 5,6-ene intermediate. Hydride transfer to C6′ and proton transfer to C5′ results in the final GDP-4-keto-6-deoxymannose product. This mechanism implies the presence of 2 distinct catalytic bases; the first step (oxidation of the C4′OH) is conducted by the conserved Tyr residue, while the oxidation/reduction of the C5′ carbon and the C6′OH is presumably carried out by a conserved glutamate residue (Glu157 in the human enzyme, Glu164 in the A. thaliana enzyme) .
Several decarboxylases have been identified as members of the SDR family and are involved in cellular functions such as lipid A modification with 4-amino-4-deoxy-L-arabinose in Gram-negative bacteria or in production of UDP-xylose necessary for proteoglycan synthesis in eukaryotes [85, 86]. These SDR-type decarboxylases carry out an initial oxidation step at the C4-OH group of nucleotide-diphosphate sugars such as UDP-glucuronic acid. This leads to decarboxylation of the C6-carboxyl group and formation of UDP-4 keto arabinose or, after further reduction using the initially formed NADH, yields UDP-xylose [85, 87]. Structural analyses reveal close relationships to UDP-galactose epimerases, but clear differences exist in the active site geometry and architecture. Structure determination of ArnA, a bacterial decarboxylase, suggests a different mechanism where active site Ser and Arg residues appear to be the key catalytic residues . The eukaryotic xylose synthases utilize a UDP-glucuronic acid decarboxylation reaction with reduction of a 4-keto pentose intermediate. It is conceivable that in these enzymes the initial reaction proceeds through a central proton abstraction through the active site tyrosyl residue. However, further mechanistic details of this class of SDR enzymes are presently unknown and require clarification.
Related SDR enyzme families: conservation of the Rossmann fold with different active sites
From the examples illustrated above it has become evident that the three-dimensional folding pattern of SDRs, like those of most protein families, is more conserved than their underlying sequence motifs. This is further highlighted by structure determination of mammalian biliverdin β reductase , transcriptional regulators like fungal NmrA , proapoptotic oncogenes such as CC3/Tip30  and prokaryotic halohydrin dehalogenases . All these proteins display close to non-traceable sequence homologies despite a highly similar three-dimensional architecture related to the SDR fold. Out of these examples, biliverdin reductase β, which catalyzes the reduction of tetrapyrroles such as biliverdin IXβ and flavins, was the first to be structurally characterized. The crystal structure revealed binding of NAD(P) as well as a folding pattern with UDP-galactose epimerase as the closest structural neighbour . Although no clear candidate for a catalytic base was identified, proton transfer could be achieved either by a His residue or be directly derived from solvent. Other catalytically important residues found in SDRs, such as Asn, Ser and Lys, are absent, again highlighting the versatility of the Rossmann fold to accomodate separate active site configurations.
The SDR scaffold as redox sensor: NAD(P)(H) binding with non-enzymatic functions
Structure determination of monomeric CC3/TIP30 (human gene name HTATIP2), a proapoptotic oncogene  with metastasis suppression properties, revealed close relationships to UDP-galactose epimerase and carbonyl reductases . Although initially suspected to be a kinase , bioinformatic predictions suggested clear relationships to SDRs , such as galactose epimerase, which was experimentally verified later on . CC3/TIP30 binds NAD(P) and contains the active site residues Ser, Tyr and Lys. At present, no catalytic activity has been demonstrated for the protein. However, it is conceivable that differential NADP(H) binding is involved in regulation of other cellular functions, such as interactions of CC3/TIP30 to nuclear importins or corepressors and transcription factors such as c-myc/CIA . This is in line with observations on other types of oxidoreductases such as aldo-keto reductases (AKRs), where several members regulate potassium channel transport , or 2-hydroxyacid dehydrogenases like the C-terminal binding proteins (CTBPs), which regulate transcription by interaction with e.g. the C-terminal region of human adenovirus E1A proteins [96, 97]. In fact, similar properties have been shown for the SDR-fold fungal transcriptional regulator NmrA, which differentially binds oxidized nucleotide cofactors, thus linking redox status to interactions with transcription factors . The recent structure determination of a human ortholog to NmrA  (gene symbol NMRAL) revealed a similar SDR-type architecture, lack of classical active site residues and cofactor binding-induced structural rearrangements. Importantly, NMRAL associates with cytoskeleton components, and directly interacts with argininosuccinate synthase, implying a role as redox sensor in NO signalling. This is reminiscent of the function of methionine adenosyl transferase, consisting of catalytically active α-subunits and regulatory SDR-type β-subunits, which differentially bind NADP(H) and are postulated to act as a redox sensor module . Again, these examples demonstrate that the basic nucleotide binding scaffold can adopt other roles than merely promoting catalysis of oxidoreductase functions. This is further highlighted by RNA binding and nuclease activity of the chloroplast factor CSP41 , which lacks classical SDR active site residues. This is not the only case of oxidoreductases involved in RNA chemistry, e.g. the MDR enzyme ζ-crystallin and other Rossmann-fold enzymes like GAPDH are able to bind specific mRNAs and can regulate their stability .
Structurally and in part mechanistically related to SDRs are prokaryotic halohydrin dehalogenases (halohydrin hydrogen-halide lyases; EC 4.5.-.-), which catalyze the reversible nucleophilic displacement of a halogen by a vicinal hydroxyl group yielding an epoxide, a proton and a halide . These enzymes are of considerable biotechnological interest and are useful as potential catalysts for the production of optically pure epoxides and halohydrins, as well as in the bioremediation of halogenated aliphatics that are found in polluted soil and water.
Interest in the SDR family centers around at least three different aspects: molecular evolution, enzymology and biotechnological applications. Regarding evolution, SDRs are remarkable in demonstrating a versatile nucleotide binding domain as a central scaffold and combining this with accommodations to fit to hundreds of reactions/substrates and to literally half of all enzyme class types. Bioinformatic and structural analyses have shown huge variability in mechanistic features with no absolutely conserved residue. Instead, the conservation of the three-dimensional fold with conserved cofactor binding properties appears to be the driving force to create an enzymatic platform spanning at least three different EC classes. Regarding biotechnological applications, SDRs constitute a ‘druggable’ enzyme class, and investigations into human forms have spawned widespread biotechnological and pharmaceutical interests.
An attempt to systematize and provide a repository for the SDR family is currently ongoing, and regular updates will be available through http://www.sdrenzymes.org.
Many of the initial and joint studies mentioned were supported by the Swedish Research Council, Novo Nordisk Foundation, and the Knut and Alice Wallenberg Foundation. Subsequent work now performed at the Structural Genomics Consortium (a registered charity, no. 1097737) receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. Figure 3was kindly provided by Dr Jordi Benach, Barcelona